+ All Categories
Home > Documents > 30439010 KETOFEN CAUTION (ketoprofen)...ketoprofen ranging from 0.5 to 1.5 mg/lb n = number of...

30439010 KETOFEN CAUTION (ketoprofen)...ketoprofen ranging from 0.5 to 1.5 mg/lb n = number of...

Date post: 14-Mar-2020
Category:
Upload: others
View: 7 times
Download: 0 times
Share this document with a friend
2
NADA 140-269, Approved by FDA KETOFEN ® (ketoprofen) Sterile Solution, 100 mg/mL For intravenous use in horses only. CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION Ketoprofen is a non-steroidal anti- inflammatory agent of the propionic acid class that includes ibuprofen, naproxen and fenoprofen. Each mL of KETOFEN (ketoprofen) contains 100 mg of ketoprofen in an aqueous formulation containing: L-Arginine, 70 mg; citric acid (to adjust pH); benzyl alcohol, 0.025 g (as preservative). It is packaged in a multiple dose bottle. PHARMACOLOGY KETOFEN is a non-narcotic, non- steroidal anti-inflammatory agent with analgesic and antipyretic properties. In horses, intravenous dosages of ketoprofen ranging from 0.5 to 1.5 mg/lb resulted in dosage dependent anti- inflammatory effects in the chronic adjuvant carpitis model as depicted in the following graph. Additional studies using the same model in horses have shown that the effects of ketoprofen are maximal by 12 hours and still measurable at 24 hours after each dosage as depicted in the following graph. TOXICITY Horses were found to tolerate ketoprofen given intravenously at dosages of 0, 1, 3 and 5 mg/lb once daily for 15 consecutive days (up to five times the recommended dosage for three times the usual *sem = standard error of the mean n = number of animals 0.5 mg/lb 1.0 mg/lb 1.5 mg/lb PLACEBO MAXIMUM FLEXION (intravenous ketoprofen, mean ± sem, n = 4)* 100 90 80 70 60 50 40 0 8 16 24 32 MAXIMUM FLEXION (DEGREES) TIME (HOURS) TIME (HOURS) *sem = standard error of the mean n = number of animals MAXIMUM FLEXION (DEGREES) MAXIMUM FLEXION (mean ± sem, n = 6)* KETOPROFEN 1 mg/lb IV PLACEBO CONTROL Treatment times BASE- LINE 120 110 100 90 80 70 60 50 40 30 12 36 60 84 108 4390K FPO - I 2 of 5 30439010
Transcript

6” x 4” (4” x 1” folded) Template #634 2194000/2193000 Insert

9414 11815600 Ketofen USA

Time/Date:

CHANGES

OK

CHANGES

OK

CHANGES

OK

EDITOR’S COPYGS: DATE:

Project No. Artwork Number Description Country

Dimensions Drawing No. SKU No. Item

rev. 08JUN11

Additional Info: Colors:

Black

Mgr

GS

GA

M. WolpertN. DeShongJ. Disch

Rev GA PR GS / ART REV (LCA) GS / ART REV (FA)

3

Alias 4390KDieline

NADA 140-269, Approved by FDA

KETOFEN®

(ketoprofen)Sterile Solution, 100 mg/mL

For intravenous use in horses only.

CAUTIONF ederal law res t r ic t s t h is drug to use by or on the order of a licensed veterinarian.

DESCRIPTIONKetoprofen is a non-steroidal ant i-inflammatory agent of the propionic acid class that includes ibuprofen, naproxen and fenoprofen. Each mL of KETOFEN (ketoprofen) contains 100 mg of ketoprofen in an aqueous formulation containing: L-Arginine, 70 mg; citric acid (to adjust pH); benzyl alcohol, 0.025 g (as preservative).It is packaged in a multiple dose bottle.

PHARMACOLOGYK E T OF E N is a non -narco t ic , non -steroidal anti-inflammatory agent with analgesic and antipyretic properties.

In horses, in t ravenous dosages of ketoprofen ranging from 0.5 to 1.5 mg/lb resul ted in dosage dependent ant i-inf lammatory ef fects in the chronic adjuvant carpitis model as depicted in the following graph.

Additional studies using the same model in horses have shown that the effects of ketoprofen are maximal by 12 hours and still measurable at 24 hours after each dosage as depicted in the following graph.

TOXICITYHorses were found to tolerate ketoprofen given intravenously at dosages of 0, 1, 3 and 5 mg/lb once daily for 15 consecutive days (up to five times the recommended dosage f or t hree t imes t he usual

durat ion) with no evidence of toxic effects. In clinical studies, intravenous injection of 1 mg/lb /day for five days resulted in no injection site irritation or other side effects.At 15-fold overdose (15 mg/lb/day) for five days one of two horses developed severe laminitis, but no gross lesions or histologic changes were observed. The toxic effects observed in the horses given a 25-fold overdose (25 mg/lb/day) for f ive days included inappetence, depression, icterus, abdominal swelling and postmortem findings of gastritis, nephritis and hepatitis.

INDICATIONKETOFEN® (ketoprofen) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.

ADMINISTRATION AND DOSAGEThe recommended dosage is 1 mg /lb (1 mL/100 lbs) of body weight once daily. Treatment is administered by intravenous injection and may be repeated for up to five days. Onset of activity is within two hours with peak response by 12 hours.

CONTRAINDICATIONSThere are no known contraindications to this drug when used as directed. Intra-arterial injection should be avoided. Do not use in a horse if it has previously shown hypersensitivity to ketoprofen.

02804 4390K 11815600

CAUTIONThis product should not be used in breeding animals since the ef fects of KE TOFEN on fer t il i t y, pregnancy or fetal health in horses have not been determined.

PRECAUTIONSS t udies t o de t er mine ac t i v i t y o f K E T O F E N w h e n a d m i n i s t e r e d concomitantly with other drugs have not been conducted. Drug compatibility should be monitored closely in patients requiring adjunctive therapy.

WARNINGDo not use in horses intended for human consumption.

SIDE EFFECTSDuring inves t igat ional s tudies, no significant side effects were reported.

HOW SUPPLIEDK E T O F E N ( k e t o p r o f e n ) S o l u t i o n 100 mg /mL is available in 50 mL and 100 mL multidose bottles.Store at controlled room temperature 20° to 25°C (68° to 77°F).

Distributed by: Fort Dodge Animal Health a division of Wyeth a wholly owned subsidiary of Pfizer Inc New York, NY 10017Revised: July 2012

0.5 mg/lb1.0 mg/lb1.5 mg/lbPLACEBO

MAXIMUM FLEXION (intravenous ketoprofen,mean ± sem, n = 4)*

*sem = standard error of the meann = number of animals

100

90

80

70

60

50

400 8 16 24 32

TIME (HOURS)

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S)

0.5 mg/lb1.0 mg/lb1.5 mg/lbPLACEBO

MAXIMUM FLEXION (intravenous ketoprofen,mean ± sem, n = 4)*

*sem = standard error of the meann = number of animals

100

90

80

70

60

50

400 8 16 24 32

TIME (HOURS)

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S) 0.5 mg/lb

1.0 mg/lb1.5 mg/lbPLACEBO

MAXIMUM FLEXION (intravenous ketoprofen,mean ± sem, n = 4)*

*sem = standard error of the meann = number of animals

100

90

80

70

60

50

400 8 16 24 32

TIME (HOURS)

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S)

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S)

*sem = standard error of the meann = number of animals

MAXIMUM FLEXION (mean ± sem, n = 6)*

KETOPROFEN 1 mg/lb IVPLACEBO CONTROL

Treatment times

TIME (HOURS)

BASE-LINE

120

110

100

90

80

70

60

50

40

3012 36 60 84 108

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S)

*sem = standard error of the meann = number of animals

MAXIMUM FLEXION (mean ± sem, n = 6)*

KETOPROFEN 1 mg/lb IVPLACEBO CONTROL

Treatment times

TIME (HOURS)

BASE-LINE

120

110

100

90

80

70

60

50

40

3012 36 60 84 108

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S)

*sem = standard error of the meann = number of animals

MAXIMUM FLEXION (mean ± sem, n = 6)*

KETOPROFEN 1 mg/lb IVPLACEBO CONTROL

Treatment times

TIME (HOURS)

BASE-LINE

120

110

100

90

80

70

60

50

40

3012 36 60 84 108

4390K

FPO - I 2 of 5

30439010

11815600.indd 1 9/13/12 8:07 AM

6” x 4” (4” x 1” folded) Template #634 2194000/2193000 Insert

9414 11815600 Ketofen USA

Time/Date:

CHANGES

OK

CHANGES

OK

CHANGES

OK

EDITOR’S COPYGS: DATE:

Project No. Artwork Number Description Country

Dimensions Drawing No. SKU No. Item

rev. 08JUN11

Additional Info: Colors:

Black

Mgr

GS

GA

M. WolpertN. DeShongJ. Disch

Rev GA PR GS / ART REV (LCA) GS / ART REV (FA)

3

Alias 4390KDieline

NADA 140-269, Approved by FDA

KETOFEN®

(ketoprofen)Sterile Solution, 100 mg/mL

For intravenous use in horses only.

CAUTIONF ederal law res t r ic t s t h is drug to use by or on the order of a licensed veterinarian.

DESCRIPTIONKetoprofen is a non-steroidal ant i-inflammatory agent of the propionic acid class that includes ibuprofen, naproxen and fenoprofen. Each mL of KETOFEN (ketoprofen) contains 100 mg of ketoprofen in an aqueous formulation containing: L-Arginine, 70 mg; citric acid (to adjust pH); benzyl alcohol, 0.025 g (as preservative).It is packaged in a multiple dose bottle.

PHARMACOLOGYK E T OF E N is a non -narco t ic , non -steroidal anti-inflammatory agent with analgesic and antipyretic properties.

In horses, in t ravenous dosages of ketoprofen ranging from 0.5 to 1.5 mg/lb resul ted in dosage dependent ant i-inf lammatory ef fects in the chronic adjuvant carpitis model as depicted in the following graph.

Additional studies using the same model in horses have shown that the effects of ketoprofen are maximal by 12 hours and still measurable at 24 hours after each dosage as depicted in the following graph.

TOXICITYHorses were found to tolerate ketoprofen given intravenously at dosages of 0, 1, 3 and 5 mg/lb once daily for 15 consecutive days (up to five times the recommended dosage f or t hree t imes t he usual

durat ion) with no evidence of toxic effects. In clinical studies, intravenous injection of 1 mg/lb /day for five days resulted in no injection site irritation or other side effects.At 15-fold overdose (15 mg/lb/day) for five days one of two horses developed severe laminitis, but no gross lesions or histologic changes were observed. The toxic effects observed in the horses given a 25-fold overdose (25 mg/lb/day) for f ive days included inappetence, depression, icterus, abdominal swelling and postmortem findings of gastritis, nephritis and hepatitis.

INDICATIONKETOFEN® (ketoprofen) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.

ADMINISTRATION AND DOSAGEThe recommended dosage is 1 mg /lb (1 mL/100 lbs) of body weight once daily. Treatment is administered by intravenous injection and may be repeated for up to five days. Onset of activity is within two hours with peak response by 12 hours.

CONTRAINDICATIONSThere are no known contraindications to this drug when used as directed. Intra-arterial injection should be avoided. Do not use in a horse if it has previously shown hypersensitivity to ketoprofen.

02804 4390K 11815600

CAUTIONThis product should not be used in breeding animals since the ef fects of KE TOFEN on fer t il i t y, pregnancy or fetal health in horses have not been determined.

PRECAUTIONSS t udies t o de t er mine ac t i v i t y o f K E T O F E N w h e n a d m i n i s t e r e d concomitantly with other drugs have not been conducted. Drug compatibility should be monitored closely in patients requiring adjunctive therapy.

WARNINGDo not use in horses intended for human consumption.

SIDE EFFECTSDuring inves t igat ional s tudies, no significant side effects were reported.

HOW SUPPLIEDK E T O F E N ( k e t o p r o f e n ) S o l u t i o n 100 mg /mL is available in 50 mL and 100 mL multidose bottles.Store at controlled room temperature 20° to 25°C (68° to 77°F).

Distributed by: Fort Dodge Animal Health a division of Wyeth a wholly owned subsidiary of Pfizer Inc New York, NY 10017Revised: July 2012

0.5 mg/lb1.0 mg/lb1.5 mg/lbPLACEBO

MAXIMUM FLEXION (intravenous ketoprofen,mean ± sem, n = 4)*

*sem = standard error of the meann = number of animals

100

90

80

70

60

50

400 8 16 24 32

TIME (HOURS)

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S)

0.5 mg/lb1.0 mg/lb1.5 mg/lbPLACEBO

MAXIMUM FLEXION (intravenous ketoprofen,mean ± sem, n = 4)*

*sem = standard error of the meann = number of animals

100

90

80

70

60

50

400 8 16 24 32

TIME (HOURS)

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S) 0.5 mg/lb

1.0 mg/lb1.5 mg/lbPLACEBO

MAXIMUM FLEXION (intravenous ketoprofen,mean ± sem, n = 4)*

*sem = standard error of the meann = number of animals

100

90

80

70

60

50

400 8 16 24 32

TIME (HOURS)

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S)

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S)

*sem = standard error of the meann = number of animals

MAXIMUM FLEXION (mean ± sem, n = 6)*

KETOPROFEN 1 mg/lb IVPLACEBO CONTROL

Treatment times

TIME (HOURS)

BASE-LINE

120

110

100

90

80

70

60

50

40

3012 36 60 84 108

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S)

*sem = standard error of the meann = number of animals

MAXIMUM FLEXION (mean ± sem, n = 6)*

KETOPROFEN 1 mg/lb IVPLACEBO CONTROL

Treatment times

TIME (HOURS)

BASE-LINE

120

110

100

90

80

70

60

50

40

3012 36 60 84 108

MA

XIM

UM

F

LE

XIO

N

(DE

GR

EE

S)

*sem = standard error of the meann = number of animals

MAXIMUM FLEXION (mean ± sem, n = 6)*

KETOPROFEN 1 mg/lb IVPLACEBO CONTROL

Treatment times

TIME (HOURS)

BASE-LINE

120

110

100

90

80

70

60

50

40

3012 36 60 84 108

4390K

FPO - I 2 of 5

30439010

11815600.indd 1 9/13/12 8:07 AM


Recommended